novel
coronaviru
whose
outbreak
took
place
decemb
continu
spread
rapid
rate
worldwid
absenc
effect
vaccin
inhibitor
repurpos
de
novo
drug
design
may
offer
longerterm
strategi
combat
futur
infect
due
similar
virus
report
detail
classic
mixsolv
molecular
dynam
simul
main
proteas
mpro
enrich
evolutionari
stabil
analysi
protein
result
compar
highli
similar
sar
mpro
protein
spite
high
level
sequenc
similar
activ
site
protein
show
major
differ
shape
size
indic
repurpos
sar
drug
may
futil
furthermor
analysi
bind
site
conform
chang
simul
time
indic
flexibl
plastic
dash
hope
rapid
reliabl
drug
design
convers
structur
stabil
protein
respect
flexibl
loop
mutat
indic
viru
mutabl
pose
challeng
ration
design
smallmolecul
inhibitor
howev
residu
contribut
significantli
protein
stabil
thu
consid
key
anchor
residu
mpro
inhibitor
design
earli
decemb
first
atyp
pneumonia
outbreak
associ
novel
coronaviru
zoonot
origin
appear
wuhan
citi
hubei
provinc
china
gener
coronavirus
cov
classifi
four
major
genera
alphacoronaviru
betacoronaviru
primarili
infect
mammal
gammacoronaviru
deltacoronaviru
primarili
infect
bird
human
coronavirus
usual
caus
mild
moder
upperrespiratori
tract
ill
eg
common
cold
howev
rarer
form
cov
lethal
end
six
kind
human
cov
identifi
belong
alphacoronaviru
genera
sever
acut
respiratori
syndrom
sarscov
middl
east
respiratori
syndrom
merscov
belong
betacoronaviru
genera
aforement
cov
last
two
danger
associ
outbreak
two
epidem
begin
centuri
januari
isol
announc
new
seventh
type
human
coronaviru
classifi
betacoronaviru
base
phylogenet
analysi
genom
data
zhang
et
al
indic
close
relat
two
sarscov
sequenc
isol
bat
suggest
bat
cov
share
common
ancestor
new
viru
consid
sarslik
viru
genom
coronavirus
typic
contain
positivesens
singlestrand
rna
differ
size
rang
kb
also
includ
variabl
number
open
read
frame
orf
first
orf
largest
encod
nearli
entir
genom
nonstructur
protein
nsp
nsp
main
proteas
mpro
also
known
chymotrypsinlik
cystein
proteas
encod
found
play
fundament
role
viral
gene
express
replic
thu
attract
target
anticov
drug
design
remain
orf
encod
accessori
proteas
one
refer
sarscov
mpro
pdb
id
cocrystallis
inhibitor
without
inhibitor
pdb
id
refer
sarscov
mpro
mpro
sarscov
mpro
structur
differ
amino
acid
locat
mostli
protein
surfac
figur
supplementari
tabl
enzym
share
structur
composit
compris
three
domain
domain
residu
ii
residu
consist
antiparallel
domain
iii
residu
requir
enzymat
activ
enzym
resembl
structur
cystein
proteas
although
activ
site
lack
third
catalyt
residu
activ
site
compris
catalyt
dyad
name
particularli
stabl
water
molecul
form
least
three
hydrogen
bond
interact
surround
residu
includ
catalyt
histidin
correspond
posit
third
catalyt
member
figur
also
note
one
differ
amino
acid
mpro
name
locat
loop
flank
activ
site
caviti
closeup
activ
site
caviti
bound
inhibitor
sarscov
black
stick
blue
stick
mpro
catalyt
water
molecul
resembl
posit
third
member
catalyt
triad
adopt
cystein
proteas
shown
sarscov
black
sphere
blue
sphere
mpro
activ
site
residu
shown
red
stick
protein
structur
shown
surfac
represent
differ
residu
posit
locat
near
entranc
activ
site
mark
asterisk
blue
black
line
b
panel
total
classic
molecular
dynam
cmd
simul
sarscov
mpro
differ
start
point
run
examin
plastic
bind
caviti
combin
cmd
approach
water
molecul
use
molecular
probe
assum
provid
highli
detail
pictur
protein
interior
dynam
small
molecul
track
approach
use
determin
access
activ
site
pocket
sarscov
mpro
local
distribut
approach
use
provid
inform
overal
distribut
solvent
protein
interior
properli
examin
flexibl
activ
site
caviti
use
timewindow
mode
implement
aquaduct
softwar
analys
water
molecul
flow
caviti
ns
time
step
combin
outer
pocket
calcul
examin
plastic
maxim
access
volum
mav
bind
caviti
surprisingli
despit
high
similar
bind
caviti
sarscov
mpro
show
significantli
differ
mav
protein
reduc
mav
upon
inhibitor
bind
approxim
maxim
volum
sarscov
larger
examin
plastic
flexibl
main
proteas
bind
caviti
focus
movement
loop
surround
entranc
regul
activ
site
access
found
one
analys
loop
sarscov
mpro
name
loop
flexibl
correspond
loop
mpro
structur
adjac
loop
mildli
flexibl
figur
could
indirectli
assum
absenc
loop
crystallograph
structur
sarscov
mpro
structur
hand
flexibl
could
suggest
presenc
inhibitor
might
stabilis
loop
surround
activ
site
worth
ad
loop
carri
uniqu
mpro
residu
mixedsolv
md
simul
run
cosolv
acetonitril
acn
benzen
bnz
dimethylsulfoxid
dmso
methanol
meo
phenol
phn
urea
ure
cosolv
use
specif
molecular
probe
repres
differ
chemic
properti
function
group
would
complement
differ
region
bind
site
protein
use
small
molecul
track
approach
analys
flow
mpro
structur
identifi
region
molecul
trap
andor
cage
locat
within
protein
global
hotspot
figur
supplementari
figur
insid
bind
caviti
local
hotspot
figur
supplementari
figur
size
locat
type
hotspot
differ
provid
complementari
inform
global
hotspot
identifi
potenti
bindinginteract
site
whole
protein
structur
addit
provid
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
inform
region
attract
particular
type
molecul
wherea
local
hotspot
describ
actual
avail
bind
space
specif
caviti
figur
largest
number
densest
hotspot
locat
within
bind
caviti
region
essenti
mpro
dimeris
ii
iii
domain
bind
caviti
particularli
occupi
urea
benzen
phenol
hotspot
especi
interest
sinc
solvent
exhibit
differ
chemic
properti
close
inspect
bind
site
caviti
provid
detail
cosolv
distribut
benzen
hotspot
mpro
structur
localis
deep
insid
activ
site
caviti
sarscov
mpro
featur
mostli
benzen
hotspot
caviti
entranc
figur
interest
sinc
absenc
cosolv
molecul
water
access
volum
mpro
smaller
case
sarscov
mpro
underlin
huge
plastic
bind
caviti
suggest
larg
conform
chang
induc
interact
potenti
ligand
also
interest
global
local
hotspot
sarscov
mpro
structur
locat
proxim
loop
potenti
regul
access
activ
site
figur
localis
local
hotspot
identifi
bind
site
caviti
sarscov
main
proteas
hotspot
individu
cosolv
repres
sphere
size
reflect
hotspot
densiti
colour
code
follow
purpl
urea
green
dimethylsulfoxid
yellowmethanol
orang
acetonitril
pink
phenol
red
benzen
activ
site
residu
shown
red
stick
protein
structur
shown
cartoon
represent
loop
grey
gener
abovement
find
indic
potenti
difficulti
identif
specif
inhibitor
toward
mpro
protein
first
bind
site
characteris
huge
plastic
probabl
even
distant
activ
site
mutat
modifi
mpro
bind
properti
secondli
loop
regul
access
activ
site
contribut
discrimin
potenti
inhibitor
therefor
addit
mutat
abovement
region
could
appear
evolut
significantli
chang
affin
mpro
ligand
verifi
potenti
threat
mutabl
mpro
protein
perform
correl
mutat
analysi
cma
multipl
sequenc
align
ii
analysi
contribut
alreadi
identifi
differ
sarscov
mpro
protein
stabil
iii
predict
possibl
mutat
caus
probabl
mutat
substitut
singl
nucleotid
mrna
sequenc
mpro
inde
analysi
perform
comul
softwar
show
within
viral
mpro
evolutionarycorrel
residu
dispers
throughout
structur
indirectli
support
previou
find
distant
amino
acid
mutat
contribut
significantli
bind
site
plastic
worth
ad
among
evolutionarycorrel
residu
identifi
also
differ
sarscov
mpro
locat
loop
figur
linker
loop
cma
analysi
indic
particular
residu
loop
evolutionarycorrel
linker
loop
correl
residu
loop
wherea
correl
select
residu
domain
loop
shown
mutat
amino
acid
distant
activ
site
residu
evolutionari
correl
like
modifi
activ
site
access
figur
localis
evolutionarycorrel
residu
mpro
black
stick
cma
analysi
provid
four
group
evolutionarycorrel
residu
mpro
structur
present
cartoon
activ
site
residu
shown
red
stick
uniqu
residu
mpro
blue
stick
asterisk
indic
residu
belong
evolutionarycorrel
residu
uniqu
sarscov
mpro
loop
colour
black
loop
orang
pleas
note
within
one
correl
group
upper
left
residu
loop
correl
linker
loop
residu
iii
domain
interest
examin
energet
effect
amino
acid
replac
mpro
structur
calcul
energet
contribut
protein
stabil
use
foldx
expect
differ
total
energi
sarscov
mpro
variant
introduc
mutat
mpro
residu
repres
signific
energi
chang
supplementari
tabl
biggest
energi
reduct
found
mutat
kcalmol
mutat
slightli
reduc
total
energi
supplementari
tabl
investig
possibl
mutat
mpro
singl
nucleotid
substitut
introduc
main
proteas
gene
substitut
singl
nucleotid
caus
translat
differ
amino
acid
compar
correspond
residu
wildtyp
structur
appropri
mutat
propos
foldx
calcul
energet
favour
potenti
mutat
chosen
base
kcalmol
threshold
figur
supplementari
tabl
energet
favour
potenti
mutat
includ
amino
acid
solventexpos
protein
surfac
accord
netsurfp
result
result
show
gener
expos
amino
acid
like
mutat
addit
potenti
mutabl
bind
caviti
investig
residu
belong
bind
caviti
found
within
inhibitor
calcul
differ
gibb
free
energi
protein
fold
respect
wildtyp
protein
supplementari
tabl
present
result
heat
map
energet
favour
potenti
mutat
shown
green
neutral
white
unfavour
red
figur
interestingli
residu
form
catalyt
dyad
name
also
prone
mutat
howev
probabl
import
messag
come
analysi
potenti
mutabl
loop
mutat
four
stabilis
effect
protein
rest
effect
nearneutr
result
indic
futur
evolut
mpro
protein
significantli
reduc
potenti
use
protein
molecular
target
coronaviru
treatment
due
highli
probabl
develop
drug
resist
viru
mutat
shown
previou
research
track
water
molecul
bind
caviti
combin
local
distribut
approach
identifi
catalyt
water
posit
inde
despit
differ
size
dynam
bind
caviti
sarscov
mpro
main
identifi
water
alway
found
posit
next
residu
locat
assum
indic
catalyt
water
mpro
replac
miss
third
catalyt
site
amino
acid
first
qualiti
check
methodolog
approv
approach
initi
investig
report
previou
research
overal
plastic
mpro
requir
proper
enzym
function
case
sarscov
truncat
linker
loop
gave
rise
signific
reduct
protein
activ
confirm
proper
orient
linker
allow
shift
dimer
monomer
form
dimeris
enzym
necessari
catalyt
activ
proper
conform
seven
ntermin
residu
nfinger
requir
mpro
replac
alanin
leucin
shown
replac
alanin
residu
sarscov
mpro
lead
enhanc
catalyt
activ
enzym
accompani
chang
structur
dynam
enzym
transmit
effect
mutat
catalyt
centr
inde
replac
observ
mpro
allow
two
domain
iii
approach
littl
closer
comparison
md
simul
main
proteas
initi
differ
start
conform
without
inhibitor
suggest
besid
plastic
whole
protein
larg
differ
access
bind
caviti
andor
accommod
shape
caviti
respons
inhibitor
bound
also
differ
outer
pocket
maxim
access
volum
two
structur
sarscov
main
proteas
apo
sarscov
mpro
structur
use
start
point
md
simul
shown
largest
mav
analys
system
result
suggest
sarscov
main
proteas
bind
caviti
highli
flexibl
chang
volum
shape
significantli
alter
ligand
bind
find
indic
seriou
obstacl
classic
virtual
screen
approach
drug
design
gener
numer
novel
compound
consid
potenti
inhibitor
sarscov
reach
stage
clinic
trial
lack
success
might
relat
abovement
plastic
bind
caviti
compound
use
dock
virtual
screen
research
aim
sarscov
also
novel
approach
focus
mostli
structur
similar
bind
pocket
ignor
fact
actual
avail
bind
space
differ
significantli
gener
ration
drug
design
success
tool
identif
possibl
inhibitor
case
atom
resolut
structur
target
protein
known
new
target
highli
homolog
structur
avail
logic
strategi
would
seek
chemic
similar
compound
creat
deriv
inhibitor
find
compound
predict
higher
affin
new
target
structur
origin
one
would
expect
work
protein
mpro
use
sarscov
protein
templat
howev
indepth
analysi
indic
differ
situat
take
place
major
shape
size
differ
emerg
due
bind
site
flexibl
continu
effort
diamond
light
sourc
group
perform
massiv
xchem
crystallograph
fragment
screen
mpro
support
find
larg
bind
site
flexibl
supplementari
figur
therefor
repurpos
sar
drug
may
success
due
major
shape
size
differ
despit
dock
method
enhanc
sampl
consid
analysi
water
hotspot
show
catalyt
water
hotspot
domin
water
distribut
insid
bind
caviti
remain
water
hotspot
correspond
much
lower
water
densiti
level
border
bind
caviti
suggest
rather
hydrophob
neutral
interior
bind
caviti
mixmd
simul
perform
variou
cosolv
confirm
observ
largest
number
densest
hotspot
locat
within
bind
caviti
region
essenti
mpro
dimeris
ii
iii
domain
deep
insight
local
hotspot
distribut
variou
cosolv
underlin
larg
differ
bind
site
plastic
smaller
bind
caviti
enlarg
significantli
presenc
highli
hydrophob
cosolv
benzen
hotspot
detect
deep
insid
caviti
also
near
loop
contrast
case
sarscov
benzen
hotspot
locat
vicin
loop
conclus
may
also
impli
suffici
potent
inhibitor
sarscov
andor
mpro
need
abl
open
way
activ
site
success
bind
caviti
result
support
regulatori
role
loop
alert
unwarr
use
simplifi
approach
drug
reposit
dock
difficulti
target
activ
site
mpro
also
explain
evolutionari
studi
potenti
mutabl
analysi
alreadi
point
loop
like
regul
access
activ
site
enabl
entranc
favour
small
molecul
block
entri
unfavour
one
second
import
loop
start
vicin
bind
site
link
ii
domain
iii
domain
contribut
significantli
mpro
dimeris
initi
analysi
effect
amino
acid
replac
sarscovmpro
mpro
structur
stabil
expect
provid
neutral
stabilis
contribut
protein
fold
inde
replac
found
stabilis
protein
fold
eg
kcalmol
almost
neutral
charact
eg
analysi
potenti
risk
mpro
structur
evolut
within
bind
caviti
suggest
mutat
residu
contribut
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ligand
bind
access
activ
site
energet
favour
like
occur
residu
prone
mutat
would
provid
inact
enzym
eg
residu
form
catalyt
dyad
therefor
could
consid
blind
alley
enzym
evolut
other
eg
amino
acid
loop
could
significantli
modifi
inhibitor
bind
mode
mpro
locat
prone
mutat
residu
regulatori
loop
question
effort
mpro
activ
site
inhibitor
design
long
term
strategi
howev
result
indic
also
residu
energet
unfavour
mutat
eg
could
provid
anchor
success
drug
design
outlast
coronaviru
mpro
variabl
futur
altern
would
suggest
target
region
ii
iii
domain
contribut
dimer
format
h
server
use
proton
sarscov
main
proteas
structur
pdb
id
respect
use
standard
paramet
ph
miss
loop
model
ad
use
correspond
loop
model
water
molecul
place
use
combin
placev
algorithm
amber
leap
use
immers
model
truncat
octahedr
box
water
molecul
prepar
system
simul
use
forc
addit
na
ion
ad
sarscov
respect
amber
softwar
use
run
simul
system
minimis
procedur
consist
step
involv
steepest
descent
step
follow
step
conjug
gradient
energi
minimis
decreas
constraint
protein
backbon
kcal
x
x
final
minimis
constraint
conjug
gradient
energi
minim
next
gradual
heat
perform
k
k
ps
use
langevin
thermostat
temperatur
coupl
constant
ps
constant
volum
period
box
equilibr
product
stage
run
use
constant
pressur
period
boundari
condit
ns
fs
step
ns
fs
time
step
respect
constant
temperatur
maintain
use
weakcoupl
algorithm
ns
product
simul
time
temperatur
coupl
constant
ps
longrang
electrostat
interact
model
use
particl
mesh
ewald
method
nonbond
cutoff
shake
algorithm
coordin
save
interv
ps
six
differ
cosolv
acetonitril
acn
benzen
bnz
dimethylsulfoxid
dmso
methanol
meo
phenol
phn
urea
ure
select
perform
mixedsolv
md
simul
chemic
structur
cosolv
molecul
download
chemspid
databas
dedic
set
paramet
prepar
paramet
adopt
work
nikitin
lyubartsev
paramet
ure
modifi
use
forc
field
obtain
paramet
singl
molecul
rest
cosolv
molecul
paramet
prepar
use
antechamb
gasteig
charg
packmol
softwar
use
build
initi
system
consist
protein
proton
accord
previous
describ
procedur
water
particular
cosolv
molecul
na
ion
ad
mpro
sarscov
mpro
respect
assum
percentag
concentr
cosolv
exceed
case
acn
dmso
meo
ure
case
bnz
phn
phenol
see
supplementari
tabl
mixedsolv
md
simul
procedur
minim
equilibr
product
carri
use
amber
packag
ident
classic
md
simul
heat
stage
differ
extend
ps
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
aquaduct
softwar
use
track
water
cosolv
molecul
molecul
interest
enter
socal
object
defin
sphere
around
centr
geometri
activ
site
residu
name
trace
within
scope
region
defin
interior
convex
hull
mpro
sar
mpro
atom
visualis
made
pymol
aquaduct
use
analys
maxim
access
volum
mav
defin
outer
pocket
outer
pocket
repres
maxim
possibl
space
could
explor
track
molecul
aquaduct
use
detect
region
occupi
molecul
interest
identifi
densest
site
use
local
solvent
distribut
approach
socal
hotspot
could
calcul
local
andor
global
base
distribut
track
molecul
visit
object
local
scope
without
visit
object
global
consid
potenti
bind
site
clariti
size
sphere
repres
particular
hotspot
chang
reflect
occup
level
select
signific
hotspot
consist
indic
point
show
highest
densiti
particular
region
set
point
space
small
group
hotspot
determin
group
defin
distanc
radiu
point
found
within
distanc
shorter
determin
radiu
point
part
given
group
count
toward
group
design
group
point
one
show
highest
densiti
chosen
repres
place
mpro
download
pdb
complex
inhibitor
pdb
id
tblastn
run
base
protein
amino
acid
sequenc
ident
region
mpro
complet
genom
sequenc
id
obtain
blastx
calcul
run
select
region
polyprotein
ncbi
refer
sequenc
amino
acid
sequenc
ident
previous
download
mpro
receiv
foldx
softwar
use
insert
substitut
structur
sarscov
mpro
analys
chang
two
structur
singlepoint
mutat
introduc
sar
structur
residu
sarscov
mpro
mutat
respect
mpro
residu
differ
total
energi
wildtyp
mpro
mutant
structur
calcul
investig
possibl
mutat
mpro
singl
nucleotid
substitut
introduc
main
proteas
gene
substitut
singl
nucleotid
caus
translat
differ
amino
acid
correspond
residu
wildtyp
structur
appropri
mutat
propos
foldx
softwar
sarscov
mpro
download
pdb
pdb
id
blast
run
base
amino
acid
sequenc
result
sequenc
viral
main
proteas
similar
chain
sarscov
mpro
obtain
clustal
omega
use
prepar
align
sequenc
comul
employ
calcul
correl
amino
acid
base
result
group
posit
sarscov
mpro
sequenc
select
whose
amino
acid
occurr
strongli
depend
paper
report
molecular
dynam
simul
main
proteas
mpro
whose
crystal
structur
releas
compar
mpro
highli
similar
sarscov
protein
spite
high
level
sequenc
similar
two
homolog
protein
activ
site
show
major
differ
shape
size
indic
repurpos
sar
drug
may
futil
furthermor
detail
analysi
bind
pocket
conform
chang
simul
time
indic
flexibl
plastic
dash
hope
rapid
reliabl
drug
design
moreov
find
show
presenc
flexibl
loop
regul
access
bind
site
pocket
success
inhibitor
may
need
abil
reloc
loop
entranc
bind
catalyt
pocket
howev
mutat
lead
chang
amino
acid
sequenc
loop
affect
fold
protein
may
result
put
inhibitor
inabl
access
bind
pocket
provid
probabl
develop
drug
resist
avoid
situat
futur
evolut
mpro
wipe
effort
focu
key
function
residu
whose
mutat
destabilis
protein
author
declar
conflict
interest
main
proteas
cov
coronavirus
orf
open
read
frame
